John E. Byom has served as a director since January 2006 and currently serves as the Company’s Independent Lead Director. He was Chief Executive Officer of Classic Provisions Inc., a specialty foods distribution company, from October 2007 until the business was sold and he retired in June 2019. Previously, he spent 26 years with International Multifoods Corporation, including service as Vice President, Finance and Chief Financial Officer from March 2000 to June 2004. Following the sale of International Multifoods to The J.M. Smucker Company, he served as President of Multifoods Foodservice and Bakery Products until March 2005. Earlier roles included President of U.S. Manufacturing, Vice President, Finance and IT for the North American Foods Division, and various finance and internal audit positions. Mr. Byom previously served on the board of MGP Ingredients Inc. He earned a B.A. in Accounting from Luther College.
 

• Audit & Finance Committee
• Compensation & Talent Management Committee

Celeste A. Clark, Ph.D. has served as a director since February 2021. She has been principal of Abraham Clark Consulting, LLC since November 2011, advising on nutrition and health policy, regulatory affairs and leadership development, and has served as an adjunct professor in Michigan State University’s Department of Food Science and Human Nutrition since January 2012. Dr. Clark previously served as Senior Vice President, Global Policy and External Affairs and Chief Sustainability Officer of Kellogg Company, concluding a nearly 35-year career in which she led global health, nutrition and regulatory science initiatives, corporate communications, public affairs, philanthropy and administrative functions. She serves on the boards of The Hain Celestial Group, Inc. and Darling Ingredients Inc. and as a trustee of the W.K. Kellogg Foundation. She previously served on several public company boards. Dr. Clark earned a Ph.D. in Food Science from Michigan State University and received an honorary Ph.D. in Humanities in 2021.
 

• Compensation and Talent Management Committee
• Nominating and Corporate Governance Committee Chair

James C. D’Arecca has served as a director since August 2023. He has served as Executive Vice President and Chief Financial Officer of Haemonetics Corporation, a medical technology company, since April 2022. Previously, he was Chief Financial Officer of TherapeuticsMD, Inc. from June 2020 to April 2022 and Senior Vice President and Chief Accounting Officer of Allergan plc, formerly Actavis plc, from August 2013 until its merger with AbbVie Inc. in May 2020. Earlier, he served as Chief Accounting Officer of Bausch & Lomb and held finance and business development roles of increasing responsibility at Merck & Co., Inc. and Schering-Plough Corporation. Mr. D’Arecca began his career at PricewaterhouseCoopers LLP, where he focused on pharmaceuticals, medical devices and consumer products. He earned a B.S. in Accounting from Rutgers University and an M.B.A. from Columbia University and is a Certified Public Accountant.

• Audit & Finance Committee Chair
• Nominating and Corporate Governance Committee

Sheila A. Hopkins has served as a director since August 2015. Ms. Hopkins formerly served as the Interim Chief Executive Officer of Cutera, Inc., an energy based and aesthetic devices company, from April 2023 to August 2023. Previously she served as President, Global Vision Care and Executive Vice President of Bausch + Lomb, a healthcare company, from September 2011 until her retirement in August 2013. From September 1997 to August 2011, Ms. Hopkins worked at Colgate-Palmolive, a leading consumer products company, where she held several senior executive positions including Vice President and General Manager, Personal Care, Vice President, Global Business Development and Vice President and General Manager, Professional Oral Care. Prior to that, she held significant marketing and sales positions at Procter & Gamble, American Cyanamid and Tambrands. Ms. Hopkins previously served on the boards of Cutera, Inc. and Warnaco Inc. She has also served on the Board of the Consumer Healthcare Products Association. Ms. Hopkins earned a B.A. in History from Wellesley College.

• Audit & Finance Committee
• Nominating and Corporate Governance Committee

John F. Kelly has served as a director since May 2024. He retired in June 2022 after a 40-year career at Pfizer Inc., where he was a member of the Pfizer Global Supply Leadership Team and the Pfizer PAC Board of Directors. He concluded his Pfizer career as Vice President, Quality Operations and Environment, Health & Safety, with responsibilities spanning pharmaceutical and consumer product operations, manufacturing strategy, business development, quality and environmental, health and safety matters. Mr. Kelly served as Chair of the board of Zydus Cadila Oncology Private Limited, a Pfizer joint venture, from March 2019 to June 2022, after serving as a director from December 2015. He is Chair of the Board of Trustees of Wakeman Boys & Girls Club and a member of the Worcester Polytechnic Institute Engineering Dean’s Advisory Board. Mr. Kelly earned a degree in Chemical Engineering from Worcester Polytechnic Institute and an M.B.A. in Operations Management from Pace University.

• Nominating and Corporate Governance Committee
• Compensation and Talent Management Committee

Ronald M. Lombardi was elected Chair of the Board in May 2017 and has served as a director and as President and Chief Executive Officer of the Company since June 2015. He previously served as the Company’s Chief Financial Officer from December 2010 to November 2015. Before joining Prestige, Mr. Lombardi held senior finance and operating roles at Medtech Group Holdings, Waterbury International Holdings and Cannondale Sports Group, including service as Chief Financial Officer and Chief Operating Officer. Earlier in his career, he held finance leadership roles at Gerber Scientific Inc. and worked at Emerson Electric, Scovill Fasteners, Inc. and Go/Dan Industries. Mr. Lombardi serves on the board of ACCO Brands Corporation, where he chairs the Audit Committee. He earned a B.S. from Springfield College and an M.B.A. from American International College and has been a licensed Certified Public Accountant.

Dawn M. Zier, Chair, Compensation and Talent Management Committee, has served as a director since May 2020. Ms. Zier was named an Operating Partner in April 2026 and has served as an Executive Mentor since 2020 at The ExCo Group, a global firm of experienced CEOs and global business leaders who bring real-world experiences, leadership development, and coaching to Fortune 500 C-Suites and their teams. Ms. Zier was the President and CEO and a member of the board of directors of the publicly traded company, Nutrisystem, Inc., a leading direct-to-consumer/ecommerce provider of weight loss solutions and services, from November 2012 until its March 2019 acquisition by Tivity Health, Inc. Ms. Zier then continued with Tivity Health, a leading provider of fitness and social engagement solutions, serving as President/COO and a member of its board of directors, to help with the integration efforts through December 2019. Prior to Nutrisystem, she served in a variety of executive positions at Reader’s Digest Association, a global media and data marketing company, including President of International from 2011-2012, President of Europe from 2009-2011, President of Global Consumer Marketing from 2008-2009, and President of North America Consumer Marketing from 2005-2008. Ms. Zier also serves as Chair of the Board of The Hain Celestial Group, Inc. (organic and natural products) and is a Director for Acorns (fintech). Ms. Zier has previously served on several other public and private company boards where she has chaired Nominating and Governance, Compensation, and Special Committees. She has also served on the boards of multiple marketing and media entities, including the Data and Marketing Association’s (DMA) board from 2008 to 2015, where she was a voting director and on the executive committee. Ms. Zier earned her MBA and Master of Engineering from the Massachusetts Institute of Technology. Additionally, she has received her Corporate Director Certification from Harvard Business School in 2020 and a certificate in Artificial Intelligence: Implications for Business Strategy from MIT Sloan School of Management in 2025. She was recognized as a Director100 by the National Association of Corporate Directors in 2022 and a Director to Watch by Directors & Boards in 2025.

• Audit & Finance Committee
• Compensation and Talent Management Committee Chair